EP2890384
Lyfjagjafarkerfi og aðferðir til að meðhöndla krabbamein í þvagblöðru sem inniheldur oxalí-platín
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
3.9.2013EP published:
3.11.2021EP application number:
13765839.9
EP translation filed:
21.12.2021Grant published:
15.1.2022EPO information:
European Patent Register
Max expiry date:
2.9.2033Expiry date:
2.9.2023
Title in English:
DRUG DELIVERY SYSTEMS AND METHODS FOR TREATMENT OF BLADDER CANCER COMPRISING OXALIPLATINLanguage of the patent:
English
Timeline
Today
3.9.2013EP application
3.11.2021EP Publication
21.12.2021Translation submitted
15.1.2022Registration published
2.9.2023Expires
Owner
Name:
TARIS Biomedical LLCAddress:
113 Hartwell Ave, Lexington, MA 02421, US
Inventor
Name:
GIESING, DennisAddress:
Lee's Summit, Missouri 64082, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261696027 PDate:
31.8.2012Country:
US
Classification
Categories:
A61K 31/555, A61K 9/00, A61M 31/00, A61P 13/10, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 16.8.2022
Expires: 2.9.2023
Payer: Árnason Faktor ehf.